Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.505
-0.122 (-19.44%)
At close: Nov 4, 2024, 4:00 PM
0.510
+0.005 (1.01%)
After-hours: Nov 4, 2024, 7:59 PM EST

Cyclacel Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-17.51-22.56-21.2-18.46-8.45-7.83
Upgrade
Depreciation & Amortization
0.020.030.030.040.020.02
Upgrade
Loss (Gain) From Sale of Assets
------0.04
Upgrade
Stock-Based Compensation
1.111.471.511.160.430.47
Upgrade
Other Operating Activities
-0.06-0.070.040.17-0.09-0.07
Upgrade
Change in Accounts Payable
0.310.32.583.030.03-2.21
Upgrade
Change in Other Net Operating Assets
4.624.71-3.78-4.480.120.21
Upgrade
Operating Cash Flow
-11.51-16.11-20.83-18.54-7.93-9.45
Upgrade
Capital Expenditures
--0.01-0.01-0.03-0.1-0.01
Upgrade
Sale of Property, Plant & Equipment
-----0.04
Upgrade
Investing Cash Flow
--0.01-0.01-0.03-0.10.03
Upgrade
Issuance of Common Stock
7.261.053.221.9425.994.05
Upgrade
Preferred Dividends Paid
-0.1-0.2-0.2-0.2-0.2-0.2
Upgrade
Dividends Paid
-0.1-0.2-0.2-0.2-0.2-0.2
Upgrade
Other Financing Activities
-----0.06-
Upgrade
Financing Cash Flow
7.160.85321.7429.53.85
Upgrade
Foreign Exchange Rate Adjustments
0.190.3-0.38-0.020.05-0.05
Upgrade
Net Cash Flow
-4.16-14.97-18.213.1521.52-5.62
Upgrade
Free Cash Flow
-11.51-16.12-20.83-18.57-8.03-9.46
Upgrade
Free Cash Flow Margin
-14391.25%-3837.62%----
Upgrade
Free Cash Flow Per Share
-6.38-18.94-27.76-31.20-33.15-173.83
Upgrade
Cash Income Tax Paid
--4.84-3.31-1.36-1.29-1.16
Upgrade
Levered Free Cash Flow
-7.66-11.76-15.34-12.21-6.16-7.46
Upgrade
Unlevered Free Cash Flow
-7.64-11.76-15.34-12.21-6.16-7.46
Upgrade
Change in Net Working Capital
-3.86-2.65-0.42-0.61-0.141.88
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.